Implantable Cardioverter Defibrillator Therapy for Ambulatory Ventricular Tachycardia:. Are We Using an Elephant Gun?

2004 ◽  
Vol 15 (6) ◽  
pp. 665-666
Author(s):  
ALAN H. KADISH
2014 ◽  
Vol 41 (3) ◽  
pp. 329-331 ◽  
Author(s):  
Fayaz Ahmad Hakim ◽  
Anil Pandit ◽  
Farouk Mookadam ◽  
Sylvia Mamby

Benign cardiac fibroma is rarely reported in adults. Its clinical symptoms are related to outflow obstruction or dysrhythmias. We present the case of a 70-year-old woman who had a syncopal episode from ventricular tachycardia caused by cardiac fibroma. Because of unfavorable tumor anatomy, the patient was not a candidate for surgical excision, and she declined orthotopic heart transplantation. To prevent sudden cardiac death, we placed an implantable cardioverter-defibrillator, and the patient remained well throughout the 2-year follow-up period. To our knowledge, this is the first report of implantable cardioverter-defibrillator therapy to treat an adult patient's unresectable cardiac fibroma.


Circulation ◽  
2012 ◽  
Vol 125 (7) ◽  
pp. 967-969 ◽  
Author(s):  
Polychronis Dilaveris ◽  
Panagiota Pietri ◽  
Dimitris Tsiachris ◽  
Konstantinos Gatzoulis ◽  
Christodoulos Stefanadis

2021 ◽  
pp. 36-42
Author(s):  
Gerald M Lawrie

The treatment of drug-refractory chronic ventricular tachycardia (VT) has undergone a revolution over the last 50 years. We now have automatic implantable cardioverter defibrillator therapy with pace-terminating capabilities, and catheter ablation of VT has refined mapping and improved methods of lesion generation. Between 1980 and 1993, Houston Methodist Hospital became a leader in the diagnosis and surgical ablation of VT and other arrhythmias. This is a brief account of that period and some of the experiences and lessons that have led to significant advances used today.


Sign in / Sign up

Export Citation Format

Share Document